Covered recipient · General Payments record
JESSICA L LEFFERS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$428.40
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.40 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $268.48 | 9 |
| Exeltis, USA Inc. | $79.24 | 4 |
| BAXTER HEALTHCARE | $32.10 | 1 |
| Biogen, Inc. | $32.01 | 2 |
| MILLICENT US INC | $16.57 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $428.40 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $28.97 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139560947 | CMS |
| Astellas Pharma US Inc | $15.75 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139560969 | CMS |
| Astellas Pharma US Inc | $18.08 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139560921 | CMS |
| Astellas Pharma US Inc | $125.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139560997 | CMS |
| Astellas Pharma US Inc | $21.60 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139561007 | CMS |
| Astellas Pharma US Inc | $17.85 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139561021 | CMS |
| Astellas Pharma US Inc | $22.61 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139561045 | CMS |
| Astellas Pharma US Inc | $10.38 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139561072 | CMS |
| Astellas Pharma US Inc | $8.24 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139561057 | CMS |
| Baxter Healthcare | $32.10 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120534955 | CMS |
| Biogen, Inc. | $18.06 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104867638 | CMS |
| Biogen, Inc. | $13.95 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104856136 | CMS |
| Exeltis, USA Inc. | $22.15 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015189 | CMS |
| Exeltis, USA Inc. | $19.11 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015191 | CMS |
| Exeltis, USA Inc. | $22.26 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015193 | CMS |
| Exeltis, USA Inc. | $15.72 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015195 | CMS |
| MILLICENT US INC | $16.57 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150915606 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.